Answers are grounded in this paper and cite their sources.
This study presents a quantum mechanical (QM)-based workflow utilizing semiempirical methods for estimating ligand binding poses in protein-ligand complexes, focusing on kinases of pharmaceutical relevance: CDK2, CK2, p38α, and CAMK1DA. The protocol integrates xTB-based docking with PM6-D3H4X rescoring within a QM/MM framework, aiming to enhance the structural accuracy over traditional docking methods. Drug-like and fragment-like ligands were tested across different receptor structures to assess robustness for CDK2 and CK2. Results show that for drug-like ligands the QM approach reproduces experimental poses. However, performance is less consistent for the fragment-like ligands we have considered, perhaps due to structural ambiguity and weak binding interactions limiting accuracy.
No takes yet. Share an insight, caveat, or question.
Mattelaer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: